Country: United States
Language: English
Source: NLM (National Library of Medicine)
VANCOMYCIN HYDROCHLORIDE (UNII: 71WO621TJD) (VANCOMYCIN - UNII:6Q205EH1VU)
Hospira, Inc.
INTRAVENOUS
PRESCRIPTION DRUG
Vancomycin hydrochloride for injection is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. It is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride for injection is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. Vancomycin hydrochloride for injection is effective in the treatment of staphylococcal endocarditis. Its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin structure infections. When staphylococcal infections are localiz
Vancomycin Hydrochloride for Injection, USP is supplied as a sterile powder in single-dose fliptop vials that contain the vancomycin equivalent of either 500 mg, 750 mg, 1 g or 1.5 g. NDC 0409-4332-01 Tray of 10 Single-dose Fliptop Vials 500 mg/vial NDC 0409-6531-02 Tray of 10 Single-dose Fliptop Vials 750 mg/vial NDC 0409-6533-01 Tray of 10 Single-dose Fliptop Vials 1 g/vial NDC 0409-6533-21 Carton of 10 Single-dose Fliptop Vials 1 g/vial NDC 0409-3515-01 Tray of 10 Single-dose Fliptop Vials 1.5 g/vial Prior to reconstitution, store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]
Abbreviated New Drug Application
VANCOMYCIN HYDROCHLORIDE- VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION HOSPIRA, INC. ---------- VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP FLIPTOP VIAL FOR INTRAVENOUS USE To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin hydrochloride for injection and other antibacterial drugs, vancomycin hydrochloride for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Vancomycin hydrochloride for injection, USP is a lyophilized powder, for preparing intravenous (IV) infusions, in vials each containing the equivalent of 500 mg, 750 mg, 1 g or 1.5 g vancomycin base. 500 mg of the base are equivalent to 0.34 mmol, 750 mg of the base are equivalent to 0.51 mmol, 1 g of the base are equivalent to 0.67 mmol and 1.5 g of the base are equivalent to 1.01 mmol. When reconstituted with Sterile Water for Injection to a concentration of 50 mg/mL, the pH of the solution is between 2.5 and 4.5. This product is oxygen sensitive. Vancomycin Hydrochloride for Injection, USP should be administered intravenously in diluted solution (see DOSAGE AND ADMINISTRATION), AFTER RECONSTITUTION FURTHER DILUTION IS REQUIRED BEFORE USE. Vancomycin is a tricyclic glycopeptide antibiotic derived from _Amycolatopsis orientalis_ (formerly _Nocardia orientalis_). The chemical name for vancomycin hydrochloride is 3S- [3_R_*,6_S_*(_S_*),7_S_*,22_S_*,23_R_*,26_R_*,36_S_*,38a_S_*]]-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3- amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]- 10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32- pentahydroxy-6-[[4-methyl-2-(methylamino)-1-oxopentyl]amino]-2,5,24,38,39- pentaoxo-22_H_-8,11:18,21-dietheno-23,36- (iminomethano)-13,16:31,35-dimetheno- 1_H_,16_H_-[1,6,9]oxadiazacyclohexadecino[4,5- _m_][10,2,16]- benzoxadiazacyclotetracosine-26-carboxylic acid, monohydrochloride. The molecular formula is C H Cl N O ∙ HCl and Read the complete document